EZH2 and ovarian carcinoma: Additionally we found EZH2 is highly expressed in the SKOV3 3rd cell line, a subline of SKOV3 with an expanded stem cell pool established by in vivo chemotherapy, and helped to maintain stemness and drug resistance of ovarian cancer stem cells.